Natural products derived from botanicals are ubiquitous across the food, pharmaceutical, and cosmetic industries. However, successfully transitioning a botanical from the laboratory bench to the consumer market requires a multifaceted research strategy driven by a singular concept: visualising the ending. In translational natural product research, the “visualised ending” is not merely a published paper; it is a safe, legally compliant, and commercially viable finished product. This plenary explores how working backward from the intended market claim and regulatory classification dictates the foundational hard science, sustainable process optimization, and quality control metrics required for success. Key themes explored in this plenary include:

• The Regulatory Blueprint: How a product’s intended use dictates its legal framework and subsequent experimental design. We will navigate the Malaysian regulatory landscape, distinguishing between health foods governed by Food Safety and Quality (FSQ) and supplements/medicines under the National Pharmaceutical Regulatory Agency (NPRA).
• Tailored Experimental Architectures: Designing precise safety and efficacy validations based on the target category. We will examine specific experimental pathways for Health Foods, Food-Drug Interface (FDI) products, Traditional Medicines, and Natural Products with active therapeutic claims.
• Translational Communication: The art of converting complex, hard science into accessible, highly regulated consumer formats. This covers translating experimental data into compliant product labels, marketing flyers, and audiovisual media that resonate with the masses.

Ultimately, by designing experiments with the final regulatory classification and consumer messaging firmly in mind, researchers can efficiently navigate market segmentation while ensuring that the primary objective—uncompromising consumer safety—remains at the forefront of the process.

Keywords. Extended abstract, submission, conference, formatting, iCoMB2026